临床医生对肉芽肿在ANCA相关血管炎诊断、管理与结局中作用的看法
该研究调查了35个国家142名有AAV诊疗经验的医生,询问其对肉芽肿影响AAV诊断、治疗和结局的看法,以及对36种表现由肉芽肿所致频率的估计。结果显示医生普遍认为肉芽肿性表现对治疗反应不同、增加复发和器官损伤风险,但肉芽肿性表现的存在并未改变重型AAV诱导缓解的治疗选择。
要点
- 医生中位Likert评分≥5(七分制,相当于部分同意)认为肉芽肿性表现治疗反应不同、增加复发和器官损伤风险。
- 36种表现中4种被中位≥75%的病例认为由肉芽肿所致,19种中位≤25%,13种处于中间水平。
- 肉芽肿所致表现的程度与重型AAV诱导缓解治疗改变无关(各情景P值0.26-0.93)。
核心结论
- 有血管炎经验的医生对AAV哪些表现由肉芽肿所致、哪些不是总体一致,并认为肉芽肿性炎症改变AAV自然史和治疗。
- 但肉芽肿性表现的存在并未改变重型AAV诱导缓解的治疗选择。
研究设计与样本
- 调查了有AAV患者诊疗经验的医生,询问AAV经验、肉芽肿对诊断治疗结局影响的看法、36种AAV表现中肉芽肿出现的频率、以及肉芽肿改变特定表现诱导治疗选择的程度。
- 收到来自35个国家的142份回复,使用描述性统计和多变量线性回归分析。
主要发现
- 回复的中位Likert评分≥5(七分制,相当于部分同意)认为肉芽肿性表现对治疗反应不同、增加复发风险并增加器官损伤。
- 36种表现中4种被中位≥75%的病例认为由肉芽肿所致(0=从不,100=总是由肉芽肿所致),19种中位≤25%,13种处于中间中位数。
- 肉芽肿所致表现的程度与重型AAV诱导缓解治疗改变无关(各情景P值0.26-0.93)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: It is unclear whether clinicians agree which manifestations of ANCA-associated vasculitides (AAV) is associated with necrotizing granulomas or if their presence affects clinical decision-making. METHODS: We surveyed physicians experienced in caring for individuals with AAV, querying: experience with AAV; beliefs concerning how granulomas affect the diagnosis, treatments and outcomes of AAV; beliefs concerning the frequency with which granulomas are found in 36 manifestations of AAV; and degree to which granulomas change choice of induction therapy for specific manifestations of AAV. We analysed responses using descriptive statistics and multivariable linear regression. RESULTS: We received 142 responses from 35 countries. Responses had a median Likert response ≥5 on a seven-point scale (equal to 'partially agree') that granulomatous manifestations respond differently to therapy, increase risk of relapse and increase organ damage. Four of 36 manifestations were believed to be caused by granulomas in a median of ≥75% of cases (on a scale of 0 = never to 100 = always caused by granuloma), 19 in a median of ≤25% of cases, and 13 in intermediate medians. The perceived degree to which granulomas caused manifestations was not associated with changes in therapy to induce remission in severe AAV (P-values 0.26-0.93 across scenarios). CONCLUSIONS: Physicians experienced in vasculitis generally agree on which manifestations of AAV are and are not caused by granulomas and that granulomatous inflammation alters the natural history and treatment of AAV. However, the presence of granulomatous manifestations did not alter treatment choices to induce remission in severe AAV.
引用
- Junek M, Fussner LA, Mendel A, et al. Clinician views concerning the prevalence and impact of granulomas on the diagnosis, management, and outcomes of ANCA-associated vasculitis. Rheumatology (Oxford). 2026. PMID: 41191924. doi:10.1093/rheumatology/keaf585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。